Postural tachycardia syndrome - Current experience and concepts

Nature Reviews Neurology

Volumn 8, Issue 1, 2012, Pages 22-34

  Mathias, Christopher J ^a,b   Low, David A ^a   Iodice, Valeria ^a   Owens, Andrew P ^a   Kirbis, Mojca ^c   Grahame, Rodney ^d  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; BISOPROLOL; CATECHOLAMINE; CLONIDINE; FLUDROCORTISONE; IVABRADINE; MIDODRINE; NORADRENALIN; OCTREOTIDE; PROPRANOLOL; PYRIDOSTIGMINE;

ANXIETY DISORDER; AUTONOMIC DYSFUNCTION; BASAL CELL NEVUS SYNDROME; BLOOD PRESSURE MEASUREMENT; CATECHOLAMINE BLOOD LEVEL; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DIZZINESS; DRUG DOSE TITRATION; EHLERS DANLOS SYNDROME; GASTROINTESTINAL SYMPTOM; GENE; GENE MUTATION; HEAD TILTING; HEART PALPITATION; HEART RATE VARIABILITY; HUMAN; JOINT HYPERMOBILITY; MYOCARDIAL PERFUSION IMAGING; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PANIC; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; PRURITUS; REVIEW; SINGLE DRUG DOSE; SLC6A2 GENE; SYNCOPE; TACHYCARDIA; VALSALVA MANEUVER;

HUMANS; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME;

EID: 84655167973     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2011.187     Document Type: Review

References (110)

1. Rosen, S. G. & Cryer, P. E. Postural tachycardia syndrome. Reversal of sympathetic hyperresponsiveness and clinical improvement during sodium loading. Am. J. Med. 72, 847-850 (1982). (Pubitemid 12112434)
2. Schondorf, R. & Low, P. A. Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia? Neurology 43, 132-137 (1993). (Pubitemid 23035371)
3. Thieben, M. J. et al. Postural orthostatic tachycardia syndrome: The Mayo clinic experience. Mayo Clin. Proc. 82, 308-313 (2007). (Pubitemid 46348932)
4. Benrud-Larson, L. M. et al. Quality of life in patients with postural tachycardia syndrome. Mayo Clin. Proc. 77, 531-537 (2002). (Pubitemid 34587341)
5. Schondorf, R., Benoit, J., Wein, T. & Phaneuf, D. Orthostatic intolerance in the chronic fatigue syndrome. J. Auton. Nerv. Syst. 75, 192-201 (1999). (Pubitemid 29101601)
6. Da Costa, J. M. On irritable heart; a clinical study of a form of functional cardiac disorder and its consequences. Am. J. Med. Sci. 121, 2-52 (1871).
7. Rudolf, R. D. The irritable heart of soldiers (soldier's heart). Can. Med. Assoc. J. 6, 796-810 (1916).
8. Lewis, T. The tolerance of physical exertion, as shown by soldiers suffering from so-called "irritable heart." Br. Med. J. 1, 363-365 (1918).
9. Wood, P. Da Costa's syndrome (or effort syndrome). Lecture I. Br. Med. J. 1, 767-772 (1941).
10. Wood, P. Da Costa's syndrome (or effort syndrome). Lecture II. Br. Med. J. 1, 805-811 (1941).
11. Wood, P. Da Costa's syndrome: Aetiology. Lecture III. Br. Med. J. 1, 845-851 (1941).
12. Holmgren, A. Vasoregulatory asthenia. Can. Med. Assoc. J. 96, 904-907 (1967).
13. Streeten, D. H. Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs. J. Clin. Invest. 86, 1582-1588 (1990). (Pubitemid 20372607)
14. Hoeldtke, R. D., Dworkin, G. E., Gaspar, S. R. & Israel, B. C. Sympathotonic orthostatic hypotension: A report of four cases. Neurology 39, 34-40 (1989).
15. Freeman, R. et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton. Neurosci. 161, 46-48 (2011).
16. Sandroni, P., Opfer-Gehrking, T. L., McPhee, B. R. & Low, P. A. Postural tachycardia syndrome: Clinical features and follow-up study. Mayo Clin. Proc. 74, 1106-1110 (1999). (Pubitemid 30243243)
17. Mathias, C. J. in Neurology: A Queen Square Textbook Ch. 23 (eds Clarke, C. et al.) 871-892 (Wiley Blackwell, Chichester, 2009).
18. Hoad, A., Spickett, G., Elliott, J. & Newton, J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM 101, 961-965 (2008).
19. Khurana, R. K. & Eisenberg, L. Orthostatic and non-orthostatic headache in postural tachycardia syndrome. Cephalalgia 31, 409-415 (2011).
20. Zarate, N. et al. Unexplained gastrointestinal symptoms and joint hypermobility: Is connective tissue the missing link? Neurogastroenterol. Motil. 22, 252-e78 (2010).
21. O'Leary, M. L., Smith, C. P., Erickson, J. R., Eidelman, B. H. & Chancellor, M. B. Neurovesical dysfunction in postural tachycardia syndrome (PoTS). Int. Urogynecol. J. Pelvic Floor Dysfunct. 13, 139-140 (2002). (Pubitemid 34591432)
22. Gazit, Y., Nahir, A. M., Grahame, R. & Jacob, G. Dysautonomia in the joint hypermobility syndrome. Am. J. Med. 115, 33-40 (2003). (Pubitemid 36831119)
23. Tinkle, B. T. et al. The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am. J. Med. Genet. A 149, 2368-2370 (2009).
24. Ross, J. & Grahame, R. Easily missed: Joint hypermobility syndrome. BMJ 342, c7167 (2011).
25. Stewart, J. M. Microvascular filtration is increased in postural tachycardia syndrome. Circulation 107, 2816-2822 (2003). (Pubitemid 36705992)
26. Joyner, M. J. & Masuki, S. PoTS versus deconditioning: The same or different? Clin. Auton. Res. 18, 300-307 (2008).
27. Fu, Q. et al. Cardiac origins of the postural orthostatic tachycardia syndrome. J. Am. Coll. Cardiol. 55, 2858-2868 (2010).
28. Mathias, C. J. & Bannister, R. in Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System 4th edn Ch. 20 (eds Mathias, C. J. & Bannister, R.) 169-195 (Oxford University Press, New York, 2002).
29. Jordan, J., Shannon, J. R., Diedrich, A., Black, B. K. & Robertson, D. Increased sympathetic activation in idiopathic orthostatic intolerance: Role of systemic adrenoreceptor sensitivity. Hypertension 39, 173-178 (2002). (Pubitemid 34098107)
30. Haensch, C. A., Lerch, H., Schlemmer, H., Jigalin, A. & Isenmann, S. Cardiac neurotransmission imaging with 123I-meta-iodobenzylguanidine in postural tachycardia syndrome. J. Neurol. Neurosurg. Psychiatry 81, 339-343 (2010).
31. Singer, W. et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology 62, 612-618 (2004). (Pubitemid 38252804)
32. Yusuf, S. & Camm, A. J. The sinus tachycardias. Nat. Clin. Pract. Cardiovasc. Med. 2, 44-52 (2005). (Pubitemid 40834200)
33. Mathias, C. J. & Galizia, G. in Endocrinology Adult and Pediatric 6th edn Vol. 1 Ch. 113 (eds Jameson, J. L. & De Groot, L. J.) 2063-2082 (Saunders Elsevier, Philadelphia, 2010).
34. Betterle, C. & Morlin, L. Autoimmune Addison's disease. Endocr. Dev. 20, 161-172 (2011).
35. Lenders, J. W., Eisenhofer, G., Mannelli, M. & Pacak, K. Phaeochromocytoma. Lancet 366, 665-675 (2005). (Pubitemid 41176020)
36. Bush, V. E., Wight, V. L., Brown, C. M. & Hainsworth, R. Vascular responses to orthostatic stress in patients with postural tachycardia syndrome (PoTS), in patients with low orthostatic tolerance, and in asymptomatic controls. Clin. Auton. Res. 10, 279-284 (2000). (Pubitemid 32093915)
37. Stewart, J. M. Pooling in chronic orthostatic intolerance: Arterial vasoconstrictive but not venous compliance defects. Circulation 105, 2274-2281 (2002). (Pubitemid 34535338)
38. Sandroni, P., Novak, V., Opfer-Gehrking, T. L., Huck, C. A. & Low, P. A. Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome. Clin. Auton. Res. 10, 1-5 (2000). (Pubitemid 32250278)
39. Jacob, G. et al. The neuropathic postural tachycardia syndrome. N. Engl. J. Med. 343, 1008-1014 (2000).
40. Bonyhay, I. & Freeman, R. Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation 110, 3193-3198 (2004). (Pubitemid 39525065)
41. Novak, V., Novak, P., Opfer-Gehrking, T. L. & Low, P. A. Postural tachycardia syndrome: Time frequency mapping. J. Auton. Nerv. Syst. 61, 313-320 (1996). (Pubitemid 26426566)
42. Vernino, S. et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 343, 847-855 (2000).
43. Furlan, R. et al. Chronic orthostatic intolerance: A disorder with discordant cardiac and vascular sympathetic control. Circulation 98, 2154-2159 (1998). (Pubitemid 28527475)
44. Garland, E. M., Raj, S. R., Black, B. K., Harris, P. A. & Robertson, D. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 69, 790-798 (2007). (Pubitemid 47300937)
45. Low, P. A., Sandroni, P., Joyner, M. & Shen, W. K. Postural tachycardia syndrome (PoTS). J. Cardiovasc. Electrophysiol. 20, 352-358 (2009).
46. Shibao, C. et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension 45, 385-390 (2005). (Pubitemid 40315808)
47. Khurana, R. K. Takotsubo cardiomyopathy in a patient with postural tachycardia syndrome. Clin. Auton. Res. 18, 43-47 (2008). (Pubitemid 351640087)
48. Stewart, J. M., Glover, J. L. & Medow, M. S. Increased plasma angiotensin II in postural tachycardia syndrome (PoTS) is related to reduced blood flow and blood volume. Clin. Sci. (Lond.) 110, 255-263 (2006). (Pubitemid 43241487)
49. Jacob, G. et al. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am. J. Med. 103, 128-133 (1997). (Pubitemid 27352117)
50. Streeten, D. H., Thomas, D. & Bell, D. S. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am. J. Med. Sci. 320, 1-8 (2000). (Pubitemid 30471283)
51. Kit, L. C. et al. Overactive bladder in patients with postural tachycardia syndrome [abstract 1505]. J. Urol. 185 (Suppl.), e603-e604 (2011).
52. Raj, S. R. et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 111, 1574-1582 (2005). (Pubitemid 40525156)
53. Raj, S. R. & Robertson, D. Blood volume perturbations in the postural tachycardia syndrome. Am. J. Med. Sci. 334, 57-60 (2007). (Pubitemid 47067447)
54. Gordon, V. M., Opfer-Gehrking, T. L., Novak, V. & Low, P. A. Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome. Clin. Auton. Res. 10, 29-33 (2000). (Pubitemid 32250283)
55. Kanjwal, K. et al. Erythropoietin in the treatment of postural orthostatic tachycardia syndrome. Am. J. Ther. http://dx.doi.org/10.1097/MJT. 0b013e3181ef621a.
56. Freeman, R., Lirofonis, V., Farquhar, W. B. & Risk, M. Limb venous compliance in patients with idiopathic orthostatic intolerance and postural tachycardia. J. Appl. Physiol. 93, 636-644 (2002). (Pubitemid 34810228)
57. Stewart, J. M. & Montgomery, L. D. Regional blood volume and peripheral blood flow in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 287, H1319-H1327 (2004). (Pubitemid 39096682)
58. Stewart, J. M., Medow, M. S., Glover, J. L. & Montgomery, L. D. Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 290, H665-H673 (2006).
59. Stewart, J. M., Medow, M. S. & Montgomery, L. D. Local vascular responses affecting blood flow in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 285, H2749-H2756 (2003). (Pubitemid 37443096)
60. Stewart, J. M., Medow, M. S., Montgomery, L. D. & McLeod, K. Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow. Am. J. Physiol. Heart Circ. Physiol. 286, H1216-H1222 (2004). (Pubitemid 38248640)
61. Jordan, J. et al. Raised cerebrovascular resistance in idiopathic orthostatic intolerance: Evidence for sympathetic vasoconstriction. Hypertension 32, 699-704 (1998). (Pubitemid 28480547)
62. Novak, V. et al. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke 29, 1876-1881 (1998). (Pubitemid 28399981)
63. Low, P. A., Novak, V., Spies, J. M., Novak, P. & Petty, G. W. Cerebrovascular regulation in the postural orthostatic tachycardia syndrome (POTS). Am. J. Med. Sci. 317, 124-133 (1999). (Pubitemid 29521403)
64. Ocon, A. J., Medow, M. S., Taneja, I., Clarke, D. & Stewart, J. M. Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 297, H664-H673 (2009).
65. Schondorf, R., Benoit, J. & Stein, R. Cerebral autoregulation in orthostatic intolerance. Ann. NY Acad. Sci. 940, 514-526 (2001). (Pubitemid 32623419)
66. Paulson, O. B., Strandgaard, S. & Edvinsson, L. Cerebral autoregulation. Cerebrovasc. Brain Metab. Rev. 2, 161-192 (1990).
67. Panerai, R. B. Cerebral autoregulation: From models to clinical applications. Cardiovasc. Eng. 8, 42-59 (2008).
68. Schondorf, R., Benoit, J. & Stein, R. Cerebral autoregulation is preserved in postural tachycardia syndrome. J. Appl. Physiol. 99, 828-835 (2005). (Pubitemid 41214491)
69. Skeavington, I., Bleasdale-Barr, K., Sanchez-Manso, J. C., Low, D. A. & Mathias, C. Haemodynamic responses to exercise and orthostatic stress in the postural tachycardia syndrome and vasovagal syncope [abstract]. Clin. Auton. Res. 20, 148-149 (2010).
70. Masuki, S. et al. Arterial baroreflex control of heart rate during exercise in postural tachycardia syndrome. J. Appl. Physiol. 103, 1136-1142 (2007). (Pubitemid 47605946)
71. Masuki, S. et al. Reduced stroke volume during exercise in postural tachycardia syndrome. J. Appl. Physiol. 103, 1128-1135 (2007). (Pubitemid 47605945)
72. Winker, R. et al. Endurance exercise training in orthostatic intolerance: A randomized, controlled trial. Hypertension 45, 391-398 (2005). (Pubitemid 40315809)
73. Fu, Q. et al. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension 58, 167-175 (2011).
74. Robertson, D. et al. Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann. NY Acad. Sci. 940, 527-543 (2001). (Pubitemid 32623420)
75. Shannon, J. R. et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N. Engl. J. Med. 342, 541-549 (2000). (Pubitemid 30117894)
76. Garland, E. M. et al. Endothelial NO synthase polymorphisms and postural tachycardia syndrome. Hypertension 46, 1103-1110 (2005). (Pubitemid 41533011)
77. Stewart, J. M., Taneja, I., Glover, J. & Medow, M. S. Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 294, H466-H473 (2008).
78. Maslen, C. L., Corson, G. M., Maddox, B. K., Glanville, R. W. & Sakai, L. Y. Partial sequence of a candidate gene for the Marfan syndrome. Nature 352, 334-337 (1991). (Pubitemid 21912352)
79. Keller, N. R. & Robertson, D. Familial orthostatic tachycardia. Curr. Opin. Cardiol. 21, 173-179 (2006). (Pubitemid 44315079)
80. Esler, M. et al. The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J. Psychopharmacol. 20 (Suppl.), 60-66 (2006). (Pubitemid 44576660)
81. Khurana, R. K. Experimental induction of panic-like symptoms in patients with postural tachycardia syndrome. Clin. Auton. Res. 16, 371-377 (2006). (Pubitemid 46009482)
82. Masuki, S. et al. Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety. J. Appl. Physiol. 102, 896-903 (2007). (Pubitemid 46377010)
83. Stewart, J. M., Medow, M. S., Cherniack, N. S. & Natelson, B. H. Postural hypocapnic hyperventilation is associated with enhanced peripheral vasoconstriction in postural tachycardia syndrome with normal supine blood flow. Am. J. Physiol. Heart Circ. Physiol. 291, H904-H913 (2006). (Pubitemid 44175100)
84. Raj, V. et al. Psychiatric profile and attention deficits in postural tachycardia syndrome. J. Neurol. Neurosurg. Psychiatry 80, 339-344 (2009).
85. Raj, S. R. The postural tachycardia syndrome (PoTS): Pathophysiology, diagnosis & management. Indian Pacing Electrophysiol. J. 6, 84-99 (2006).
86. Frankenhaeuser, M., Jarpe, G. & Matell, G. Effects of intravenous infusions of adrenaline and noradrenaline on certain psychological and physiological functions. Acta Physiol. Scand. 51, 175-186 (1961).
87. Gorman, A. L. & Dunn, A. J. ß-adrenergic receptors are involved in stress-related behavioral changes. Pharmacol. Biochem. Behav. 45, 1-7 (1993).
88. Kang, E. H. & Yu, B. H. Anxiety and ß-adrenergic receptor function in a normal population. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 733-737 (2005).
89. Yu, B. H., Kang, E. H., Ziegler, M. G., Mills, P. J. & Dimsdale, J. E. Mood states, sympathetic activity, and in vivo ß-adrenergic receptor function in a normal population. Depress. Anxiety 25, 559-564 (2008).
90. Pyke, R. E. & Greenberg, H. S. Norepinephrine challenges in panic patients. J. Clin. Psychopharmacol. 6, 279-285 (1986). (Pubitemid 17206869)
91. Nutt, D. & Lawson, C. Panic attacks. A neurochemical overview of models and mechanisms. Br. J. Psychiatry 160, 165-178 (1992).
92. Yeragani, V. K., Pohl, R., Bär, K. J., Chokka, P. & Tancer, M. Exaggerated beat-to-beat R amplitude variability in patients with panic disorder after intravenous isoproterenol. Neuropsychobiology 55, 213-218 (2007). (Pubitemid 47525242)
93. Bulbena, A. et al. Is joint hypermobility related to anxiety in a nonclinical population also? Psychosomatics 45, 432-437 (2004). (Pubitemid 39166916)
94. Bulbena, A. et al. Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res. 46, 59-68 (1993). (Pubitemid 23066272)
95. Bulbena, A., Pailhez, G. & Gago, J. "Connective tissue" between panic disorder and dysautonomia. Am. J. Med. 116, 783 (2004).
96. Kanjwal, K., Karabin, B., Sheikh, M., Kanjwal, Y. & Grubb, B. P. New onset postural orthostatic tachycardia syndrome following ablation of AV node reentrant tachycardia. J. Interv. Card. Electrophysiol. 29, 53-56 (2010).
97. Ewing, D. J. Diabetic autonomic neuropathy and the heart. Diabetes Res. Clin. Pract. 30 (Suppl.), 31-36 (1996). (Pubitemid 126352574)
98. El-Sayed, H. & Hainsworth, R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75, 134-140 (1996). (Pubitemid 26068690)
99. van Lieshout, J. J., ten Harkel, A. D. & Wieling, W. Physical manoeuvres for combating orthostatic dizziness in autonomic failure. Lancet 339, 897-898 (1992).
100. Smit, A. A. et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin. Auton. Res. 14, 167-175 (2004). (Pubitemid 38951992)
101. Grahame, R. Joint hypermobility syndrome pain. Curr. Pain Headache Rep. 13, 427-433 (2009).
102. McClellan, K. J., Wiseman, L. R. & Wilde, M. I. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension. Drugs Aging 12, 76-86 (1998).
103. Freitas, J. et al. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Clin. Auton. Res. 10, 293-299 (2000). (Pubitemid 32066011)
104. Raj, S. R. et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: Less is more. Circulation 120, 725-734 (2009).
105. McDonald, C., Frith, J. & Newton, J. L. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace 13, 427-430 (2011).
106. Raj, S. R., Black, B. K., Biaggioni, I., Harris, P. A. & Robertson, D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 111, 2734-2740 (2005). (Pubitemid 40791543)
107. Jacob, G. et al. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 96, 575-580 (1997). (Pubitemid 27329436)
108. Hoeldtke, R. D., Bryner, K. D., Hoeldtke, M. E. & Hobbs, G. Treatment of postural tachycardia syndrome: A comparison of octreotide and midodrine. Clin. Auton. Res. 16, 390-395 (2006). (Pubitemid 46009485)
109. Hoeldtke, R. D., Bryner, K. D., Hoeldtke, M. E. & Hobbs, G. Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR. Clin. Auton. Res. 17, 334-340 (2007). (Pubitemid 350276144)
110. Mathias, C. J. & Young, T. M. Plugging the leak-benefits of the vasopressin-2 agonist, desmopressin in autonomic failure. Clin. Auton. Res. 13, 85-87 (2003). (Pubitemid 36628403)